Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs geared toward expanding the horizons of cytokine-based immunotherapy, especially for cancers where cure selections remain limited. Utilize the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pipeline https://financefeeds.com/transak-expands-to-australia-with-austrac-digital-currency-exchange-approval/